Hepatic steatosis in patients with HIV-Hepatitis C Virus coinfection: is it associated with antiretroviral therapy and more advanced hepatic fibrosis?
<p>Abstract</p> <p>Background and aims</p> <p>Patients with HIV and hepatitis C virus (HCV) coinfection are at increased risk of developing hepatic steatosis. The aims of this study were to assess the prevalence of steatosis in a cohort with HIV-HCV coinfection, and to...
Main Authors: | Goldin Robert D, Verma Sumita, Main Janice |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-07-01
|
Series: | BMC Research Notes |
Online Access: | http://www.biomedcentral.com/1756-0500/1/46 |
Similar Items
-
Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
by: Martinez Valrie, et al.
Published: (2012-07-01) -
Risk of Liver Fibrosis in Hepatitis B Virus and HIV Coinfected Youths Receiving Tenofovir-Containing Antiretroviral Regimen
by: Linda Aurpibul MD, et al.
Published: (2019-01-01) -
Hepatitis B viremia in HIV-coinfected individuals under antiretroviral therapy
by: Leonardo Weissmann, et al.
Published: (2019-11-01) -
HIV and Hepatitis C Virus Coinfection, Cameroon
by: Christian Laurent, et al.
Published: (2007-03-01) -
The Prevalence and Impact of Hepatic Steatosis on Response to Direct-Acting Antiviral Therapy in HIV–HCV Coinfection
by: Leigh P. Johnson, et al.
Published: (2020-04-01)